Stryker is trading at $303.62, up 4.03% on November 2, 2026, amid a broader market rebound; no clear company-specific catalyst for the intraday rise was identified. - U.S. stocks recovered some of last week’s losses as oil prices fell and investor sentiment improved. - Stryker’s third-quarter results missed estimates, and management cut its 2026 guidance, citing softer hip and knee trends and supply constraints. This backdrop helps explain recent pressure, not Monday’s rebound.